Comparing diagnostic methods of breast cancer in early stages

Comparing the rate of sentinel node detection by using a peri-areolar blue dye injection to a peri-incisional injection of radio colloid in patients with the history of excisional biopsy of breast cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT138812201740N2

Enrollment

Registered

2010-10-20

Start date

2010-04-20

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer. Malignant neoplasm of breast

Interventions

Intervention 1: blue dye injection. Intervention 2: radiocolloid injection.

Diagnosis

blue dye injection

radiocolloid injection

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Inclusion criteria: 1- Those with recently detected stage 1 or 2 breast cancer. 2- Those who have not received any chemo/radio therapies. Exclusion criteria: 1- History of operations in axillary fossa 2- Palpable axillary lymph nodes 3- Pregnancy 4- Breast inflammatory carcinoma 5- Blue dye allergy

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Detection rate of sentinel lymph nodes by radioicolloid injection. Timepoint: 24 hours after injection. Method of measurement: gamma probe.;Detection rate of sentinel lymph nodes by blue dye injection. Timepoint: 20 minute after injection. Method of measurement: observation.	—

Secondary

Measure	Time frame
Pneumonia. Timepoint: up to one week. Method of measurement: clinical and CXray.;Skin coloration. Timepoint: up to one week. Method of measurement: observation.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Shahriar Azizi

Mashad University of Medical Sciences

AZIZISH861@MUMS.AC.IR+98 51 1802 2677

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026